BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Key Financials
Gross Profit
$4360
0.0%
Operating Income
$-46538
↑ 30.3%
Net Income
$-1291951
↓ 163.4%
EPS (Diluted)
$-0.04
↓ 100.0%
Total Liabilities
$619329.00
↓ 73.1%
Total Assets
$786.00
↓ 8.8%
Shareholders' Equity
$-618543.00
↑ 73.1%
Cash & Equivalents
$786.00
↓ 8.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D | 9/4/2026 | View on SEC |
| 8-K | 9/4/2026 | View on SEC |
| 3 | 9/4/2026 | View on SEC |
| 3 | 9/3/2026 | View on SEC |
| 4 | 9/2/2026 | View on SEC |
| 4 | 9/2/2026 | View on SEC |
| 8-K | 8/18/2026 | View on SEC |
| 8-K | 8/14/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| 8-K | 7/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BFNH |
| Company Name | BIOFORCE NANOSCIENCES HOLDINGS, INC. |
| CIK | 1310488 |
| Sector | Laboratory Analytical Instruments |
| Industry | Emerging growth company |
| Exchange | OTC |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 757-306-6090 |